Guardant Health AMEA will also be presenting one Poster Discussion and two Proffered Papers in the annual European Society for Medical Oncology Congress, taking place in Barcelona from 27th September to 1st October 2019. Here are the details of the studies which will be presented:

Poster Discussion
– TRIUMPH: Primary Efficacy of a Phase II Trial of Trastuzumab (T) and Pertuzumab (P) in Patients (pts) with Metastatic Colorectal Cancer (mCRC) with HER2 (ERBB2) Amplification (amp) in Tumor Tissue or Circulating Tumor DNA (ctDNA): A GOZILA Sub-study (EPOC1602)

Proffered Paper
– A platform trial with a registry study for rare cancers: MASTER KEY project

– Clinical development of molecular-targeted therapies for non-small cell lung cancer through nationwide genome screening in Japan (LC-SCRUM-Japan)